You are here: Industry Insights > antibody

News List

Research and Development Status and Progress of Antibody Technology (Part Ⅱ) Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
Research and Development Status and Progress of Antibody Technology (Part I) Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
How is the progress of China’s domestically produced PD-(L)1 “going global”? Yefenghong/PharmaSources
November 23, 2023
Recently, Coherus BioSciences announced that the FDA has approved the launch of PD-1 antibody toripalimab (marketed jointly by Junshi Biosciences and Coherus) for use in combination with gemcitabine/cisplatin as a first-line treatment for advanced recurre
A comprehensive review of the currently marketed ADC drugs: the industry maintains high prosperity WND
November 07, 2023
Antibody-drug conjugates (ADCs) are a class of drugs composed of antibodies targeting tumor antigens and a variable number of small molecule toxins linked through connectors.
Research Progress on the Application of Biologics in Childhood Asthma. Xiaomichong
October 30, 2023
Asthma is a heterogeneous, complex chronic disease. Children with severe asthma often experience acute exacerbations, leading to impaired lung function and poor quality of life.
Pharmaceutical Business Progress in China and Worldwide (March) PharmaSources
May 12, 2023
Progress in Pharmaceutical Business at Home and Abroad (March)
Weekly Pharma News Review | PharmaSources.com (March 21 to 25) PharmaSources/Caicai
March 30, 2022
Henlius PD-1 was launched this week, becoming the 7th China-made PD-1 monoclonal antibody and the 13th PD-1/PD-L1 monoclonal antibody that was marketed in China.
Antibody-Drug Conjugates – Understanding the "Trojan Horses" Neeta Ratanghayra
May 31, 2021
A robust strategy for targeted therapy, known as antibody-drug conjugates (ADCs), has been developed to counterfeit this challenge.
Pharmaceutical News of the Week (July. 20th-July. 24th) | PharmaSources.com - Updates on Performance,Volumn-based Procurement and Others PharmaSources/Caicai
July 29, 2020
The hottest event of the week was the official kick-off of the centralized procurement of the third batch of pharmaceutical products organized in China, with 86 specifications started to be acquired the basic information.
Pharmaceutical News of the Week (July. 13th-July. 17th) | PharmaSources.com - Updates on Policies,Transactions and Others PharmaSources/Caicai
July 22, 2020
With the third week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions, and miscellany that happened during July 13-17, including 30 pieces.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page